Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Key Laboratory of Technologies and Applications of Ultrafine Granular Powder of Chinese Materia Medica, State Administration of Traditional Chinese Medicine, China.
J Ethnopharmacol. 2018 Aug 10;222:99-106. doi: 10.1016/j.jep.2018.04.029. Epub 2018 Apr 22.
Myocardial infarction (MI) is considered as the major inducer to the morbidity and mortality related to coronary occlusion. Salvia miltiorrhiza Bunge is widely applied in the clinic for the prevention and treatment of heart diseases. The preparation of traditional herb decoction (THD) is not only time consuming but also difficult to keep uniform for every time. New usage form of Salvia miltiorrhiza Bunge with characteristics of convenience, uniform and efficiency is needed.
The aims of present study were to investigate the cardio-protection of ultrafine granular powder (UGP) of Salvia miltiorrhiza Bunge; and further compare the characteristics of UGP with THD.
MI was induced by ligation of the left anterior descending coronary artery near the main pulmonary artery. Cardio-protection of UGP or THD was evaluated based on two sets of experiments, one was acute myocardial infarction (AMI) through 7 days preventive administration, and the other one was chronic cardiac remodeling through 28 days therapeutic administration. Hemodynamic measurement was conducted to evaluate heart function and histopathological detection was used to evaluate heart structure.
No significant improvement of heart structure and function was detected for preventive administration of UGP or THD on AMI rats. While, more significant improvements on left ventricular systolic and diastolic function were detected with therapeutic treatment with 0.81 g/kg UGP than same dose of THD on rats against chronic cardiac remodeling. Both UGP and THD showed the protective effects on heart structure, especially against fibrosis with long-term therapeutic treatment.
As a new usage form of Salvia miltiorrhiza Bunge, UGP showed significant cardio-protection against myocardial remodeling with therapeutic treatment. Comparing with THD, UGP also holds the advantages of uniform, convenience and efficiency.
心肌梗死(MI)被认为是与冠状动脉闭塞相关发病率和死亡率的主要诱因。丹参被广泛应用于临床,用于预防和治疗心脏病。传统草药汤剂(THD)的制备不仅耗时,而且每次都难以保持均匀。需要具有方便、均匀和高效特点的丹参新用途形式。
本研究旨在探讨丹参超细颗粒粉末(UGP)的心脏保护作用;并进一步比较 UGP 与 THD 的特点。
通过结扎左前降支冠状动脉靠近肺动脉主干来诱导 MI。通过两组实验评估 UGP 或 THD 的心脏保护作用,一组是通过 7 天预防性给药的急性心肌梗死(AMI),另一组是通过 28 天治疗性给药的慢性心脏重塑。进行血流动力学测量以评估心功能,进行组织病理学检测以评估心脏结构。
UGP 或 THD 对 AMI 大鼠的预防性给药未显著改善心脏结构和功能。然而,与相同剂量的 THD 相比,UGP 对慢性心脏重塑的治疗性治疗可更显著地改善左心室收缩和舒张功能。UGP 和 THD 均对心脏结构显示出保护作用,尤其是对纤维化具有长期治疗作用。
作为丹参的一种新用途形式,UGP 对心肌重塑具有显著的心脏保护作用,特别是治疗性治疗。与 THD 相比,UGP 还具有均匀、方便和高效的优点。